- Home
- IRS vs MDXG Comparison
IRS vs MDXG Comparison
Compare IRS & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRS
- MDXG
- Stock Information
- Founded
- IRS 1943
- MDXG 2006
- Country
- IRS Argentina
- MDXG United States
- Employees
- IRS N/A
- MDXG N/A
- Industry
- IRS Homebuilding
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- IRS Real Estate
- MDXG Health Care
- Exchange
- IRS Nasdaq
- MDXG Nasdaq
- Market Cap
- IRS 959.8M
- MDXG 1.1B
- IPO Year
- IRS 1994
- MDXG N/A
- Fundamental
- Price
- IRS $11.90
- MDXG $6.94
- Analyst Decision
- IRS
- MDXG Buy
- Analyst Count
- IRS 0
- MDXG 1
- Target Price
- IRS N/A
- MDXG $12.00
- AVG Volume (30 Days)
- IRS 281.6K
- MDXG 416.4K
- Earning Date
- IRS 11-05-2025
- MDXG 10-29-2025
- Dividend Yield
- IRS 8.40%
- MDXG N/A
- EPS Growth
- IRS N/A
- MDXG N/A
- EPS
- IRS 0.20
- MDXG 0.21
- Revenue
- IRS $416,589,564.00
- MDXG $363,774,000.00
- Revenue This Year
- IRS N/A
- MDXG $12.68
- Revenue Next Year
- IRS N/A
- MDXG $8.18
- P/E Ratio
- IRS $5.83
- MDXG $33.02
- Revenue Growth
- IRS 29.22
- MDXG 6.85
- 52 Week Low
- IRS $10.61
- MDXG $5.47
- 52 Week High
- IRS $17.67
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- IRS 29.36
- MDXG 46.16
- Support Level
- IRS $11.33
- MDXG $6.81
- Resistance Level
- IRS $13.34
- MDXG $7.14
- Average True Range (ATR)
- IRS 0.78
- MDXG 0.19
- MACD
- IRS -0.27
- MDXG -0.04
- Stochastic Oscillator
- IRS 15.28
- MDXG 26.53
About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.